0001491519-20-000005.txt : 20200702
0001491519-20-000005.hdr.sgml : 20200702
20200702173239
ACCESSION NUMBER: 0001491519-20-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200701
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Chaim
CENTRAL INDEX KEY: 0001491519
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28666
FILM NUMBER: 201011047
MAIL ADDRESS:
STREET 1: 2601 PINE TREE DRIVE
CITY: MIAMI BEACH
STATE: FL
ZIP: 33140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMERICAN BIO MEDICA CORP
CENTRAL INDEX KEY: 0000896747
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141702188
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 122 SMITH ROAD
CITY: KINDERHOOK
STATE: NY
ZIP: 12106
BUSINESS PHONE: 5187588158
MAIL ADDRESS:
STREET 1: 122 SMITH ROAD
CITY: KINDERHOOK
STATE: NY
ZIP: 12106
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-07-01
0
0000896747
AMERICAN BIO MEDICA CORP
ABMC
0001491519
Davis Chaim
2601 PINE TREE DRIVE
MIAMI BEACH
FL
33140
1
0
0
0
Common Shares
2020-07-01
4
A
0
35461
0.37
A
240561
D
35,461 restricted common shares were issued to Davis in connection with his attendance at three (3) meetings of the Board of Directors. The meetings were held on April 22, 2020 (15,259 shares), May 20, 2020 (16,339 shares) and June 23, 2020 (3,863 shares). This stock issuance is in accordance with the director compensation structure approved by the Company's Board of Directors on March 22, 2018 (as indicted in the Company's Proxy Statement filed with the Commission on April 18, 2018).
The Company uses the average volume weighted price (VWAP) of the Company's common shares for the 10 days preceding each meeting to determine the value of the common shares. The VWAP was $0.1884 for the meeting held on April 22, 2020, $0.176 for the meeting held on May 20, 2020 and $0.7443 for the meeting held on June 23, 2020. This results in an average VWAP of $0.37.
This is the number of securities held directly by Davis. It does not include 2,978,486 common shares in the name of Revach Fund, LP (deemed to be indirectly held by Davis). Davis is the managing member of Revach Group, LLC which operates as the general partner of Revach Fund, LP.
Chaim Davis
2020-07-02